PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel Therapy
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.1229
https://www.valueinhealthjournal.com/article/S1098-3015(11)02791-4/fulltext
Section Title :
Cancer
Section Order :
1184
First Page :
A457
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02791-4&doi=10.1016/j.jval.2011.08.1229